Blood Research  2014;49(3):139-140

doi:10.5045/br.2014.49.3.139

Way to go to exploit NK cells' versatile talents for cancer immunotherapy.

Duck CHO 1

Affiliations

+expand

Country

Republic of Korea

Language

English

Abstract

No abstract available.